biguanides has been researched along with Fatty Liver in 8 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic steatohepatitis (NASH) once considered a benign process is now known to lead to progressive fibrosis and cirrhosis." | 2.43 | [Drug therapy for non-alcoholic steatohepatitis]. ( Hibi, T; Tomita, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 1 |
| Niederstrasser, H | 1 |
| Douglas, PM | 1 |
| Lin, R | 1 |
| Jaramillo, J | 1 |
| Li, Y | 1 |
| Oswald, NW | 1 |
| Zhou, A | 1 |
| McMillan, EA | 1 |
| Mendiratta, S | 1 |
| Wang, Z | 1 |
| Zhao, T | 1 |
| Lin, Z | 1 |
| Luo, M | 1 |
| Huang, G | 1 |
| Brekken, RA | 1 |
| Posner, BA | 1 |
| MacMillan, JB | 1 |
| Gao, J | 1 |
| White, MA | 1 |
| RANDIG, K | 1 |
| Tomita, K | 1 |
| Hibi, T | 1 |
| Marquié, G | 1 |
| Agid, R | 1 |
| Amiel, S | 1 |
| Guilhem, A | 1 |
| Mosin, VI | 1 |
| Jaross, W | 1 |
| Hanefeld, M | 1 |
| Stötzner, H | 1 |
| Möller, E | 1 |
| Haese, E | 1 |
2 reviews available for biguanides and Fatty Liver
| Article | Year |
|---|---|
[Drug therapy for non-alcoholic steatohepatitis].
Topics: Antihypertensive Agents; Antioxidants; Biguanides; Fatty Liver; Humans; Hypolipidemic Agents; Insuli | 2006 |
[Condition of the liver and biliary tract in diabetes mellitus].
Topics: Biguanides; Biliary Tract Diseases; Cholecystitis; Cholelithiasis; Diabetes Complications; Diabetes | 1974 |
6 other studies available for biguanides and Fatty Liver
| Article | Year |
|---|---|
Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan.
Topics: Animals; Autophagosomes; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Big | 2017 |
[DIABETES MELLITUS AND THE LIVER].
Topics: Alcoholism; Biguanides; Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Drug Therapy; Fat | 1965 |
[Prevention, by antidiabetic biguanides, of hepatic cholesteatosis induced by cholesterol in the rabbit. Histopathological examination].
Topics: Animals; Biguanides; Chemical Phenomena; Chemistry; Cholesterol; Fatty Liver; Hypoglycemic Agents; L | 1970 |
[Diagnostic and physiopathologic evidence by micro-lipid determination in liver punctures].
Topics: Adolescent; Adult; Biguanides; Biopsy; Cholesterol; Chromatography, Thin Layer; Fatty Liver; Humans; | 1970 |
[Treatment of diabetic fatty liver with Buformin].
Topics: Adult; Biguanides; Diabetes Complications; Diet Therapy; Diet, Reducing; Dietary Carbohydrates; Fatt | 1967 |
[On the clinical use of biguanides].
Topics: Aged; Biguanides; Blood Glucose; Body Weight; Cholesterol; Depression, Chemical; Diabetes Mellitus; | 1969 |